22nd Century Pre-Tax Profit Margin 2011-2024 | XXII

22nd Century pre-tax profit margin from 2011 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
22nd Century Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $0.03B $-0.05B -168.97%
2023-12-31 $0.03B $-0.06B -171.88%
2023-09-30 $0.05B $-0.10B -216.67%
2023-06-30 $0.05B $-0.05B -95.92%
2023-03-31 $0.04B $-0.04B -95.00%
2022-12-31 $0.04B $-0.04B -90.00%
2022-09-30 $0.05B $-0.05B -100.00%
2022-06-30 $0.04B $-0.04B -110.26%
2022-03-31 $0.03B $-0.04B -109.09%
2021-12-31 $0.03B $-0.03B -103.23%
2021-09-30 $0.03B $-0.02B -80.00%
2021-06-30 $0.03B $-0.02B -65.52%
2021-03-31 $0.03B $-0.02B -74.07%
2020-12-31 $0.03B $-0.02B -70.37%
2020-09-30 $0.03B $-0.02B -70.37%
2020-06-30 $0.03B $-0.03B -96.15%
2020-03-31 $0.03B $-0.03B -107.69%
2019-12-31 $0.03B $-0.03B -104.00%
2019-09-30 $0.03B $-0.03B -116.00%
2019-06-30 $0.03B $-0.01B -52.00%
2019-03-31 $0.03B $-0.01B -46.15%
2018-12-31 $0.03B $-0.01B -34.62%
2018-09-30 $0.03B $-0.00B -16.00%
2018-06-30 $0.02B $-0.01B -54.17%
2018-03-31 $0.02B $-0.01B -42.86%
2017-12-31 $0.02B $-0.01B -76.47%
2017-09-30 $0.01B $-0.01B -85.71%
2017-06-30 $0.01B $-0.01B -100.00%
2017-03-31 $0.01B $-0.01B -109.09%
2016-12-31 $0.01B $-0.01B -100.00%
2016-09-30 $0.01B $-0.01B -100.00%
2016-06-30 $0.01B $-0.01B -100.00%
2016-03-31 $0.01B $-0.01B -90.91%
2015-12-31 $0.01B $-0.01B -122.22%
2015-09-30 $0.01B $-0.01B -233.33%
2015-06-30 $0.00B $-0.01B -466.67%
2015-03-31 $0.00B $-0.02B -1500.00%
2014-12-31 $0.00B $-0.02B inf%
2014-09-30 $0.01B $-0.02B -257.14%
2014-06-30 $0.01B $-0.03B -428.57%
2013-09-30 $0.00B $-0.02B inf%
2012-09-30 $0.00B $-0.00B inf%
2011-12-31 $0.00B $-0.00B -100.00%
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.007B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $166.524B 17.47
Altria (MO) United States $84.937B 10.05
British American Tobacco (BTI) United Kingdom $73.740B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $23.230B 0.00
Universal (UVV) United States $1.254B 10.01
Turning Point Brands (TPB) United States $0.644B 12.77